Strategic R&D associates with foreign research institutes on the rise.

Since the implementation of the product patent system, the domestic drug industry strived to secure pipeline products by means of a technology licensing but largely went failure due to too competition among rival companies. To overcome this hurdle many local drug industries are trying to explore a strategic association with foreign R&D institutes.

The strategic R&D associations included an...